AzTrials
AzTrials

Radiation ExposureNCT03649451

Reference Dose Levels During Fluoroscopically Guided Procedures in Operating Rooms

An observational study of Radiation Exposure, run by Societe Francaise de Physique Medicale at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is conducted by a working group of the French Society of Medical Physics (SFPM). Its main aim is to establish reference dose levels for the most common procedures performed in operating rooms using mobile X-ray systems, hence helping medical physicists and surgeons to evaluate their practice and optimize… Read more about this study

Who is it for?
Ages 16 to 100 years
Conditions the study is for
Radiation Exposure
How many people
8,840 participants
Where
1 siteFrance
Study dates
3 Sep 2018to 30 Aug 2019
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 100 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Study population consists on unhealthy patients undergoing surgical procedures with the use of X-ray mobile equipement. 62 types of procedures, belonging to 7 surgery specialties (neurosurgery, orthopedic, digestive, urology, cardiology, vascular and multi-specialty) are included in this study. For each procedure and each participating institution among the 73 centers that have sent their participation agreement, 15 to 30 procedures will be collected and analysed.

Who may be able to join

  • Fluoroscopy guided procedures performed on adult patients (≥16 years old)
  • Fluoroscopy guided procedures performed with mobile X-ray systems. Procedures performed outside of the operating rooms but using mobile X-ray systems are included in this study.
  • Fluoroscopy guided procedures performed using mini C-arms or O-arms

Who cannot join

  • Fluoroscopy guided procedures performed on pediatric patients (<16 years old)
  • Fluoroscopy guided procedures performed with a fixed interventional radiology imaging system even if it was located in the operating rooms .
  • Medical procedures performed using both a mobile X-ray system and a fixed CT scanner.
  • Medical procedures performed using a mobile intra-operative CT scanner

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hopital Lariboisiere

    Paris, 75010

Other trials in France

About this study

Official title: Reference Dose Levels During Fluoroscopically Guided Procedures Performed Using Mobile X-ray Systems in Operating Rooms

This study is conducted by a working group of the French Society of Medical Physics (SFPM). Its main aim is to establish reference dose levels for the most common procedures performed in operating rooms using mobile X-ray systems, hence helping medical physicists and surgeons to evaluate their practice and optimize patient radiation protection.

This is a multi-centric prospective study involving 73 medical institutions of different categories (public university hospitals, clinics, centers dedicated to cancer treatment, etc.). It consists on progressively collecting anonymous data for 15 to 30 procedures from a list of 62 types of procedures, belonging to 7 surgery specialties (neurosurgery, orthopedic surgery, digestive surgery, urology, cardiology, vascular surgery and multi-specialty). Collected data include patient BMI and information about the X-ray equipment, the medical procedure and the dosimetric parameters. Data collection doesn't require the access to the patient medical record and doesn't impact his medical care.

Proposed dose reference levels will be expressed in terms of KAP (Kerma-Area-Product), fluoroscopy time and air Kerma. Moreover, multiple statistical analyses will be done to investigate the impact of different variables on the procedure X-ray doses.

Read the detailed description

Context:

Reference dose levels, introduced by the International Commission on Radiological Protection (ICRP) in 1996, are intended to help professionals using medical imaging to evaluate their practice and optimize patient's doses. European directive 2013/59/Euratom emphasizes the need to establish, use and regularly review reference levels for diagnostic and interventional procedures and to publish guidelines on this topic. Furthermore, national reference levels were established for conventional radiology and CT exams. They are used as a tool for the optimization of medical practices. Besides, a working group of the French Society of Medical Physics (SFPM) has published in 2017 reference levels for interventional radiology procedures performed in a dedicated room and using fixed angiographic equipment. Although radiation protection is a big challenge encountered in operating rooms using mobile X-ray equipment, few data are available in the literature regarding the use of this type of equipment.

In this context, the SFPM suggested the creation of a working group in 2017 to establish reference levels for the main procedures realized in the operating rooms using mobile X-ray systems. The aim of this working group is to help medical physicists and surgeons in evaluating their practice and optimizing patient radiation protection.

Scope of the study: The main purpose of the study is to establish dosimetric reference levels, in terms of KAP (Kerma-Area-Product). Additional objectives consist on proposing reference levels in terms of fluoroscopy time and air kerma and on studying the impact of different parameters (surgical specialty, body mass index, use of zoom, fluoroscopy pulse rate) on the delivered doses.

Study type and cohort: This is a multi-centric prospective study which consists on progressively collecting anonymous data for 15 to 30 procedures from a list of 62 surgical procedures (n=62) belonging to 7 different surgery specialties. Selected specialties are neurosurgery (n=12), orthopedic surgery (n=15), digestive surgery (n=6), urology (n=10), cardiology (n=6), vascular surgery (n=11), multi-specialty (n=2). 73 health institutions of different categories (University hospitals, clinics, centers dedicated to cancer treatment, etc..) confirmed their participations to the study.

Data collection: Data will be collected using a password-protected Excel spreadsheet. This excel file will be sent to all the participating institutions at the beginning of data collection. Every institution will send the excel file completed with anonymized data to the scientific responsible of the study through the secure email server of the APHP (Assistance Publique des Hopitaux de Paris)) institution.

Analysis: The main goal of this study is to publish descriptive statistics parameters (mean, standard deviation, median, 1st quartile, 3rd quartile) for each dosimetric data (KAP, fluoroscopy time, kerma, etc..) and for each category of surgical procedures. Results will be presented with a 95 percentage confidence interval.

Moreover, correlation analysis between several variables will be done. The differences between detector and equipment technologies will be also studied using appropriate statistical tests.

Keywords
Reference dose levels, Surgery, C-arm, Orthopedic, Urology, Vascular, Neurosurgery, Cardiology, Digestive, Fluoroscopy, Patient radiation protection, X-ray, Interventional radiology, Optimization, Kerma Area Product

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total KAP (Kerma-Air-Product)

    KAP or Kerma-Area-Product is the main dosimetric parameter representing the patient exposure. Participants should choose the appropriate unit of the KAP among a list of five units (microGray.m², milliGray.centimeter², centiGray.centimeter², deciGray.centimeter², Gray.centimeter²). Note that Gray is the international unit of the radiation quantity.

    Measured: KAP is provided by the X-ray equipment at the end of the procedure.

Secondary outcomes (19)
  1. Year of construction of the equipment and date of the last external quality control (QC) (yyyy)

    Year of construction of the equipment and date of the last external quality control

    Measured: baseline

  2. Image receptor type of the equipment

    Participants should specify whether the images are obtained using a flat panel detector or an X-ray image intensifier.

    Measured: baseline

  3. DACS Connection

    Participants should specify If the X-ray equipment is connected to a Dose Archiving and a Communication system (DACS) (Yes/no)

    Measured: baseline

  4. Patient weight (kg) and height (cm)

    Weight and height will be combined to report BMI in kg/m^2.

    Measured: Patient weight and height are provided from the equipment or given by the medical team during the procedure

  5. Size of Fields of View (FOV) (cm)

    Size of the smallest and largest Field of View (FOV); size of the largest FOV adapted to the size of the phantom; size of the most used FOV for the concerned procedure. (cm)

    Measured: Baseline, The most used FOV during the procedure is provided by the medical staff

  6. Differences between the displayed and measured X-ray doses (percentage)

    Differences between the displayed and measured KAP for the smallest and biggest FOV; Differences between the displayed and measured air kerma available in the last quality control (QC) report. (Percentages).

    Measured: baseline

  7. Total air kerma of the procedure including the one performed of an O-arm equipment

    Participants should specify the unit by choosing the appropriate one among a list of 5 units (micro Gray, milli Gray, centi Gray, deci Gray, Gray).

    Measured: Data are provided by the X-ray equipment at the end of the procedure

  8. Total number of image frames (number)

    Total number of image frames (number)

    Measured: Data are provided by the X-ray equipment at the end of the procedure

  9. Fluoroscopy mode used during the procedure

    Participants should specify whether continuous, pulsed or mixed fluoroscopy modes are used during the procedure

    Measured: Data are provided by the X-ray equipment at the end of the procedure

  10. Fluoroscopy pulse rate ( pulses/second)

    Measured: Data are provided by the X-ray equipment at the end of the procedure

  11. Fluoroscopy time (hh:mm:ss) of the procedure including the one performed of an O-arm equipment

    Measured: Data are provided by the X-ray equipment at the end of the procedure

  12. KAP (Kerma-Area-Product) attributable to fluoroscopy

    Participants should choose the appropriate unit of the KAP among a list of five units (µGy.m², mGy.cm², cGy.cm², dGy.cm², Gy.cm²).

    Measured: Data are provided by the X-ray equipment at the end of the procedure

  13. Medical specialty of the procedure

    Participants should specify the medical specialty of the procedure by selecting one from a predefined list of seven categories: Orthopedic surgery, neurosurgery, cardiology, vascular surgery, urology, digestive surgery and multi-specialty.

    Measured: Data are provided by the medical staff during the procedure

  14. Name/type of the procedure

    Participants should specify the medical description of the procedure.

    Measured: Data are provided by the medical staff during the procedure

  15. Additional information about the procedure giving further indications about the used materials or the anatomical region of interest.

    Measured: Data are provided by the medical staff during the procedure

  16. Total KAP for procedures performed on an O-arm equipment

    Participants should choose the appropriate unit of the KAP among a list of five units (µGy.m², mGy.cm², cGy.cm², dGy.cm², Gy.cm²).

    Measured: KAP is provided by the X-ray equipment at the end of the procedure

  17. Total DLP (Dose-Length-Product) of the procedures performed on an O-arm equipment.DLP is always expressed in mGy.cm.

    The DLP (Dose Length Product) is expressed in milliGray *centimeters (mGy.cm)

    Measured: DLP is provided by the X-ray equipment at the end of the procedure

  18. CTDIvol (Volume Computed Tomography Dose Index) of the procedures performed on an O-arm equipment. CTDI is always expressed in mGy.

    The CTDIvol is a standardized measure of radiation dose output of a CT scanner. This dose is expressed in milliGrays (mGy).

    Measured: CTDIvol is provided by the X-ray equipment at the end of the procedure

  19. Type of the dosimetric phantom used to calculate the CTDI of an acquisition for the procedures performed on an O-arm equipment.

    Participants should select between a "head phantom (16 cm)" or a "body phantom (32 cm)"

    Measured: Data are provided by the X-ray equipment at the end of the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2018
  2. Study start3 Sep 2018
  3. Primary completion30 Mar 2019
  4. Study completion30 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
8,840 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT03649451
Sponsor's protocol ID
gtsfpmnrbloc2017
Status last verified
May 2020
First submitted
2 Aug 2018
Last updated
13 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only the final results of this study will be shared with the medical physicist members of the French Society of Medical Physicist. These results are statistical data analysis based on the collected patient data. Moreover, the study main results would be probably shared with the scientific community through a published paper in a scientific peer-reviewed journal.

Questions about this trial

What is this clinical trial studying?

An observational study of Radiation Exposure, run by Societe Francaise de Physique Medicale at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total KAP (Kerma-Air-Product) (time frame: KAP is provided by the X-ray equipment at the end of the procedure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2020; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in